Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -53.81M
March 31, 2026 -51.92M
December 31, 2025 48.72M
September 30, 2025 210.79M
June 30, 2025 90.10M
March 31, 2025 1.851M
December 31, 2024 3.763M
September 30, 2024 5.032M
March 31, 2024 22.06M
December 31, 2023 25.46M
September 30, 2023 27.57M
June 30, 2023 28.34M
Date Value
March 31, 2023 37.03M
December 31, 2022 36.92M
September 30, 2022 27.13M
June 30, 2022 28.73M
March 31, 2022 28.42M
December 31, 2021 29.52M
September 30, 2021 24.78M
June 30, 2021 21.22M
March 31, 2021 3.721M
December 31, 2020 2.323M
September 30, 2020
June 30, 2020 0.2256M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
BioRegenx, Inc. -4.533M
Amaze Holdings, Inc. 9.093M
CCA Industries, Inc. 3.505M
Cyanotech Corp. 7.985M
The Estée Lauder Companies, Inc. 3.806B

Shareholders Equity (Quarterly) Related Metrics